Two of Avara’s sites provide contract development and manufacturing of active pharmaceutical ingredients (API). All facilities worldwide have a long-term record of quality and regulatory compliance.


cGMP Production Of APIs
– Multiple API facilities / capabilities
– Multi-purpose equipment and facility designs
– Optimized small-scale production (60 L – 75 L reactor capacity)
– Large-scale production (1m3 to 10m3 reactor capacity)
– Centrifuge & Nutsche filter isolation
– Process scale-up & optimization
– Alkylation, nitration, Grignard, hydride reduction & hydrogenation
– Extraction & isolation technology, fully automated PCS
– Milling & blending of APIs
– Specialization in hazardous and complex chemistry